Table 1 Demographic, clinical, laboratory, echocardiographic and treatment characteristics of patients (n = 30)
From: Cardiac magnetic resonance imaging in patients with Behçet's disease
Characteristic | Value |
|---|---|
Demographic and clinical characteristics | |
Age (years), M ± SD | 32.3 ± 8.9 |
Sex | |
Male, n (%) | 21 (70) |
Female, n (%) | 9 (30) |
Behçet's disease duration (years), median (min–max) | 3 (1.5–7) |
Height (cm), M ± SD | 171.03 ± 5.49 |
Weight (kg), M ± SD | 75.37 ± 9.22 |
BMI (kg/m2), M ± SD | 25.82 ± 3.37 |
Heart rate (bpm), M ± SD | 89.50 ± 7.69 |
SBP (mmHg), M ± SD | 127.5 ± 6.53 |
DBP (mmHg), M ± SD | 78.33 ± 9.49 |
Behcet disease activity index score, M ± SD | 4.60 ± 1.4 |
≤ 4, n (%) | 15 (50) |
> 4, n (%) | 15 (50) |
Cumulative manifestations of Behcet disease, n (%) | |
Orogenital Ulcers | 30 (100) |
Uveitis | 23 (76.7) |
Cutaneous manifestations | 11 (36.7) |
Musculoskeletal manifestations | 10 (33.3) |
Gastrointestinal tract manifestations | 1 (3.3) |
Deep venous thrombosis | 4 (13.3) |
Laboratory characteristics | |
Complete blood count | |
Hb (g/dL), M ± SD | 11.83 ± 1.01 |
WBCs (103 /mm3), M ± SD | 4.63 ± 1.5 |
PLT (103 /mm3), M ± SD | 222.8 ± 53.6 |
Serum creatinine (mg/dL), M ± SD | 0.91 ± 0.11 |
Erythrocyte sedimentation rate (mm/hr), M ± SD | 35.33 ± 10.08 |
Positive C-reactive protein, n (%) | 14 (46.7) |
Echocardiographic findings | |
Ejection fraction (%), M ± SD | 59.73 ± 5.09 |
Pericardial effusion, n (%) | 2 (6.7) |
Global hypokinesia, n (%) | 6 (20) |
Aortic valve regurge, n (%) | 1 (3.3) |
Tricuspid valve regurge, n (%) | 8 (26.7) |
Intra-cardiac thrombosis, n (%) | 1 (3.3) |
Medications used for treatment, n (%) | |
Colchicine | 30 (100) |
Steroids | 30 (100) |
Azathioprine | 14 (46.7) |
Cyclosporine | 14 (46.7) |
Anticoagulants | 5 (16.7) |
Biological agents | 10 (33.3) |
Dose of steroids (mg /day), median (min–max) | 20 (0–60) |